Verflixt! Es sieht so aus, als wenn Sie einen veralteten Browser benutzen. Wir empfehlen Ihnen dringend Ihren Browser zu aktualisieren.
Weitere Informationen über Browser und Updates finden Sie hier

PharmBioTec

PharmBioTec is a university owned CRO offering services in Biotechnological/Biopharmaceutical R&D during several stages in the drug discovery and development process. In 2010 three renowned professors of Saarland University (Hartmann, Müller, Lehr) have combined their knowledge in design, synthesis, biological evaluation, formulation and analysis of new drugs to form a flexible company that facilitates free flowing innovation transfer between university, research institute and industry. PharmBioTec’s main objective is to establish and apply new techniques in the areas of Biotechnology, Drug Discovery and Drug Delivery.
In Drug Discovery our main focus lies in the design and automated synthesis of target-oriented compound libraries for high throughput screenings. Up to 100 custom made compounds per library can be delivered in high purity.
In Drug Delivery, there is large expertise in studying drug transport across biological barriers using advanced in-vitro models, in particular of the intestinal mucosa, skin and lungs. Furthermore, appropriate carriers are developed capable of crossing these epithelial barriers and delivering an active molecule to the target.
The department of Biotechnology focuses on the isolation, formulation and analysis of proteins and peptides. Standard and innovative analytical techniques are available (LC-/CE-MS; FTIR). Furthermore the development of freeze-drying cycles is our competence

Details


Adresse:
PharmBioTec

Campus C2.2
66123 Saarbrücken
Deutschland
Arbeitsgebiet:
Forschung & Entwicklung
Expansion:
national
Webseite:
Mitarbeiteranzahl:
11-50
Gründungsjahr:
2010